SCOPUS 정보 검색 플랫폼

American Journal of Obstetrics and Gynecology

Volumn 194, Issue 5, 2006, Pages

Use of Resveratrol to improve the effectiveness of cisplatin and doxorubicin: Study in human gynecologic cancer cell lines and in rodent heart

(4) Rezk, Youssef A a Balulad, Sujata S b Keller, Rebecca S c Bennett, James A b

a Department of Obstetrics and Gynecology ^*

b Center for Immunology

c ALBANY MEDICAL COLLEGE (United States)

Author keywords

Cisplatin; Doxorubicin; Ovarian cancer; Resveratrol; Uterine cancer

Indexed keywords

CISPLATIN; DOXORUBICIN; RESVERATROL;

ANALYSIS OF VARIANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BRADYCARDIA; CANCER CELL CULTURE; CANCER INHIBITION; CARDIOTOXICITY; CELL CULTURE; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; GYNECOLOGIC CANCER; HEART; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; MUSCLE CELL; NEWBORN; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; QT PROLONGATION; RAT; RODENT; UTERUS CANCER;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRADYCARDIA; CARDIOTONIC AGENTS; CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG SYNERGISM; FEMALE; HUMANS; LONG QT SYNDROME; MICE; MYOCYTES, CARDIAC; OVARIAN NEOPLASMS; RATS; STILBENES; UTERINE NEOPLASMS;

EID: 33646111188 PISSN: 00029378 EISSN: None Source Type: Journal
DOI: 10.1016/j.ajog.2005.11.030 Document Type: Article

Times cited : (101)

References (10)

1
- 0346057794
- Resistance to chemotherapy in advanced ovarian cancer: mechanisms and current strategies
- Vasey P.A. Resistance to chemotherapy in advanced ovarian cancer: mechanisms and current strategies. Br J Cancer 89 suppl (2003) S23-S28
- (2003) Br J Cancer , vol.89 , Issue.SUPPL
- Vasey, P.A.¹

2
- 0030317942
- Anthracycline-induced cardiotoxicity
- Shan K., Lincoff A.M., and Young J.B. Anthracycline-induced cardiotoxicity. Ann Intern Med 125 (1996) 47-58
- (1996) Ann Intern Med , vol.125 , pp. 47-58
- Shan, K.¹ Lincoff, A.M.² Young, J.B.³

3
- 0023726412
- Adriamycin-induced free radical formation in the perfused rat heart: implications for cardiotoxicity
- Rajagopalan S., Politi P.M., Sinha B.K., and Myers C.E. Adriamycin-induced free radical formation in the perfused rat heart: implications for cardiotoxicity. Cancer Res 48 (1988) 4766-4769
- (1988) Cancer Res , vol.48 , pp. 4766-4769
- Rajagopalan, S.¹ Politi, P.M.² Sinha, B.K.³ Myers, C.E.⁴

4
- 0032939164
- Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway
- Huang C., Ma W.Y., Goranson A., and Dong Z. Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis 20 (1999) 237-242
- (1999) Carcinogenesis , vol.20 , pp. 237-242
- Huang, C.¹ Ma, W.Y.² Goranson, A.³ Dong, Z.⁴

5
- 0036072056
- Resveratrol induced serine phosphorylation of p53 causes apoptosis in a mutant p53 prostate cancer cell line
- Lin H.Y., Shih A., Davis F.B., Tang H.Y., Martino L.J., Bennett J.A., et al. Resveratrol induced serine phosphorylation of p53 causes apoptosis in a mutant p53 prostate cancer cell line. J Urol 168 (2002) 748-755
- (2002) J Urol , vol.168 , pp. 748-755
- Lin, H.Y.¹ Shih, A.² Davis, F.B.³ Tang, H.Y.⁴ Martino, L.J.⁵ Bennett, J.A.⁶

6
- 1942484416
- Potent induction of cellular antioxidants and phase 2 enzymes by resveratrol in cardiomyocytes: protection against oxidative and electrophilic injury
- Cao Z., and Li Y. Potent induction of cellular antioxidants and phase 2 enzymes by resveratrol in cardiomyocytes: protection against oxidative and electrophilic injury. Eur J Pharmacol 489 (2004) 39-48
- (2004) Eur J Pharmacol , vol.489 , pp. 39-48
- Cao, Z.¹ Li, Y.²

7
- 6944250259
- Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies
- Aggarwal B.B., Bhardwaj A., Aggarwal R.S., Seeram N.P., Shishodia S., and Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 24 (2004) 2783-2840
- (2004) Anticancer Res , vol.24 , pp. 2783-2840
- Aggarwal, B.B.¹ Bhardwaj, A.² Aggarwal, R.S.³ Seeram, N.P.⁴ Shishodia, S.⁵ Takada, Y.⁶

8
- 0034533580
- Striated muscle-specific beta(1D)-integrin and FAK are involved in cardiac myocyte hypertrophic response pathway
- Pham C.G., Harpf A.E., Keller R.S., Vu H.T., Shai S.Y., Loftus J.C., et al. Striated muscle-specific beta(1D)-integrin and FAK are involved in cardiac myocyte hypertrophic response pathway. Am J Physiol 279 (2000) H2916-H2926
- (2000) Am J Physiol , vol.279
- Pham, C.G.¹ Harpf, A.E.² Keller, R.S.³ Vu, H.T.⁴ Shai, S.Y.⁵ Loftus, J.C.⁶

9
- 0027214092
- Antagonistic effect of the cardioprotector (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187) on DNA breaks and cytotoxicity induced by the topoisomerase II directed drugs daunorubicin and etoposide (VP-16)
- Sehested M., Jensen P.B., Sorensen B.S., Holm B., Friche E., and Demant E.J. Antagonistic effect of the cardioprotector (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187) on DNA breaks and cytotoxicity induced by the topoisomerase II directed drugs daunorubicin and etoposide (VP-16). Biochem Pharmacol 46 (1993) 389-393
- (1993) Biochem Pharmacol , vol.46 , pp. 389-393
- Sehested, M.¹ Jensen, P.B.² Sorensen, B.S.³ Holm, B.⁴ Friche, E.⁵ Demant, E.J.⁶

10
- 0036170178
- The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful
- Juan M.E., Vinardell M.P., and Planas J.M. The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful. J Nutr 132 (2002) 257-260
- (2002) J Nutr , vol.132 , pp. 257-260
- Juan, M.E.¹ Vinardell, M.P.² Planas, J.M.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.